Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.020
+0.039 (4.01%)
Sep 11, 2026, 10:50 AM EDT - Market open
Enlivex Market Cap
Enlivex has a market cap or net worth of $17.84 million as of September 11, 2026. Its market cap has decreased by -26.35% in one year.
Market Cap
17.84M
Enterprise Value
12.72M
1-Year Change
-26.35%
Ranking
Category
Stock Price
$1.02
ChartMarket Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $17.84M, a decrease of -82.45%. That is a compound annual growth rate of -20.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 17.84M | -89.32% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 20.68M |
| Cerenome | 20.49M |
| Neuphoria Therapeutics | 20.27M |
| Pasithea Therapeutics | 20.02M |
| Chemomab Therapeutics | 19.93M |
| Allarity Therapeutics | 19.89M |
| Lipocine | 19.46M |
| Dyadic International | 18.95M |